We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

59 hedge funds and large institutions have $136M invested in Genocea Biosciences, Inc. in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more capital invested

Capital invested by funds: $87.8M → $136M (+$47.8M)

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

4% more funds holding

Funds holding: 57 → 59 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 16

Holders
59
Holders Change
+2
Holders Change %
+3.51%
% of All Funds
1.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
16
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$3.09M
2
NC
Northpointe Capital
Michigan
+$2.21M
3
PA
Perceptive Advisors
New York
+$2.05M
4
AA
AlphaMark Advisors
Kentucky
+$900K
5
AIC
AWM Investment Company
New York
+$596K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$4.46M
2
SM
Sabby Management
Florida
-$823K
3
SFM
Sphera Funds Management
Israel
-$709K
4
Millennium Management
Millennium Management
New York
-$565K
5
TI
Trexquant Investment
Connecticut
-$368K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$17K +$1.46K +46 +20%
Bank of America
52
Bank of America
North Carolina
$15K -$2.48K -78 -24%
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$7K -$318 -10 -8%
BlackRock
54
BlackRock
New York
$6K +$1.27K +40 +67%
IA
55
IFP Advisors
Florida
$6K +$39.7K +1,250 New
LTFS
56
Ladenburg Thalmann Financial Services
Florida
$2K – – –
Geode Capital Management
57
Geode Capital Management
Massachusetts
$1.06K +$6.92K +218 +1%
HR
58
Howe & Rusling
New York
$1K – – –
BC
59
Broadfin Capital
New York
– -$4.46M -105,780 Closed
SM
60
Sabby Management
Florida
– -$823K -19,517 Closed
TI
61
Trexquant Investment
Connecticut
– -$368K -8,729 Closed
RA
62
Royce & Associates
New York
– -$277K -6,575 Closed
CS
63
Credit Suisse
Switzerland
– -$192K -4,536 Closed
AQR Capital Management
64
AQR Capital Management
Connecticut
– -$146K -3,470 Closed
Balyasny Asset Management
65
Balyasny Asset Management
Illinois
– -$58K -1,388 Closed
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
– -$26.9K -638 Closed
TRCT
67
Tower Research Capital (TRC)
New York
– -$6K -150 Closed
MFS
68
MSI Financial Services
Massachusetts
– -$3K -74 Closed
1 2
3

GNCA Hedge Fund Activity: Q1 2016 in Review

59 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2016, worth a combined $136M — up 54% from $87.8M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new GNCA positions and 10 closed out — a net gain of 2 holders — while 16 added to existing stakes and 16 trimmed.

The largest buyer was Franklin Resources, adding an estimated $3.09M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.46M sold.

  • 59 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q1 2016, up from 57 in Q4 2015.
  • Funds reported $136M of Genocea Biosciences, Inc. stock for Q1 2016, up 54% quarter-over-quarter.
  • 12 funds opened new Genocea Biosciences, Inc. positions in Q1 2016 and 10 closed out, a net change of +2 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q1 2016 was Franklin Resources, an estimated $3.09M added.
  • The largest Genocea Biosciences, Inc. seller in Q1 2016 was Broadfin Capital, an estimated $4.46M sold.

Based on aggregated 13F filings for Q1 2016.